Literature DB >> 19859963

Axon responses of embryonic stem cell-derived dopaminergic neurons to semaphorins 3A and 3C.

Elisa Tamariz1, N Emmanuel Díaz-Martínez, Néstor F Díaz, Claudia M García-Peña, Iván Velasco, Alfredo Varela-Echavarría.   

Abstract

Class 3 Semaphorins are a subfamily of chemotropic molecules implicated in the projection of dopaminergic neurons from the ventral mesencephalon and in the formation of the nigrostriatal pathway (NSP) during embryonic development. In humans, loss of mesencephalic dopaminergic neurons leads to Parkinson's disease (PD). Cell replacement therapy with dopaminergic neurons generated from embryonic stem cells (ES-TH(+)) is being actively explored in models of PD. Among several requisites for this approach to work are adequate reconstruction of the NSP and correct innervation of normal striatal targets by dopaminergic axons. In this work, we characterized the response of ES-TH(+) neurons to semaphorins 3A, 3C, and 3F and compared it with that of tyrosine hidroxylase-positive neurons (TH(+)) obtained from embryonic ventral mesencephalon (VM-TH(+)). We observed that similar proportions of ES-TH(+) and VM-TH(+) neurons express semaphorin receptors neuropilins 1 and 2. Furthermore, the axons of both populations responded very similarly to semaphorin exposure: semaphorin 3A increased axon length, and semaphorin 3C attracted axons and increased their length. These effects were mediated by neuropilins, insofar as addition of blocking antibodies against these proteins reduced the effects on axonal growth and attraction, and only TH(+) axons expressing neuropilins responded to the semaphorins analyzed. The observations reported here show phenotypic similarities between VM-TH(+) and ES-TH(+) neurons and suggest that semaphorins 3A and 3C could be employed to guide axons of grafted ES-TH(+) in therapeutic protocols for PD. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19859963      PMCID: PMC2887602          DOI: 10.1002/jnr.22268

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  40 in total

Review 1.  Semaphorins and their receptors in immune cell interactions.

Authors:  Kazuhiro Suzuki; Atsushi Kumanogoh; Hitoshi Kikutani
Journal:  Nat Immunol       Date:  2007-12-17       Impact factor: 25.606

Review 2.  Role of semaphorins during axon growth and guidance.

Authors:  Eric Koncina; Lise Roth; Bertand Gonthier; Dominique Bagnard
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

3.  Estradiol promotes proliferation of dopaminergic precursors resulting in a higher proportion of dopamine neurons derived from mouse embryonic stem cells.

Authors:  Néstor F Díaz; Néstor E Díaz-Martínez; Ignacio Camacho-Arroyo; Iván Velasco
Journal:  Int J Dev Neurosci       Date:  2009-04-18       Impact factor: 2.457

4.  Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors.

Authors:  Frank Soldner; Dirk Hockemeyer; Caroline Beard; Qing Gao; George W Bell; Elizabeth G Cook; Gunnar Hargus; Alexandra Blak; Oliver Cooper; Maisam Mitalipova; Ole Isacson; Rudolf Jaenisch
Journal:  Cell       Date:  2009-03-06       Impact factor: 41.582

5.  Neuropilin-semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice.

Authors:  T Kitsukawa; M Shimizu; M Sanbo; T Hirata; M Taniguchi; Y Bekku; T Yagi; H Fujisawa
Journal:  Neuron       Date:  1997-11       Impact factor: 17.173

6.  Generation of dopamine neurons from embryonic stem cells in the presence of the neuralizing activity of bone marrow stromal cells derived from adult mice.

Authors:  Aki Shintani; Naoyuki Nakao; Koji Kakishita; Toru Itakura
Journal:  J Neurosci Res       Date:  2008-10       Impact factor: 4.164

7.  Semaphorins 3A, 3C, and 3F in mesencephalic dopaminergic axon pathfinding.

Authors:  Hebert L Hernández-Montiel; Elisa Tamariz; M Teresa Sandoval-Minero; Alfredo Varela-Echavarría
Journal:  J Comp Neurol       Date:  2008-01-20       Impact factor: 3.215

8.  Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease.

Authors:  Marius Wernig; Jian-Ping Zhao; Jan Pruszak; Eva Hedlund; Dongdong Fu; Frank Soldner; Vania Broccoli; Martha Constantine-Paton; Ole Isacson; Rudolf Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-07       Impact factor: 11.205

Review 9.  Semaphorin signaling in vascular and tumor biology.

Authors:  Gera Neufeld; Tali Lange; Asya Varshavsky; Ofra Kessler
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

10.  Gating of Sema3E/PlexinD1 signaling by neuropilin-1 switches axonal repulsion to attraction during brain development.

Authors:  Sophie Chauvet; Samia Cohen; Yutaka Yoshida; Lylia Fekrane; Jean Livet; Odile Gayet; Louis Segu; Marie-Christine Buhot; Thomas M Jessell; Christopher E Henderson; Fanny Mann
Journal:  Neuron       Date:  2007-12-06       Impact factor: 17.173

View more
  11 in total

1.  Canonical BMP-Smad signalling promotes neurite growth in rat midbrain dopaminergic neurons.

Authors:  Shane V Hegarty; Louise M Collins; Aisling M Gavin; Sarah L Roche; Sean L Wyatt; Aideen M Sullivan; Gerard W O'Keeffe
Journal:  Neuromolecular Med       Date:  2014-03-29       Impact factor: 3.843

2.  Cell Therapy From Bench to Bedside Translation in CNS Neurorestoratology Era.

Authors:  Hongyun Huang; Lin Chen; Paul Sanberg
Journal:  Cell Med       Date:  2010-01-01

3.  Cytotoxic Effects of Environmental Toxins on Human Glial Cells.

Authors:  Fiona D'Mello; Nady Braidy; Helder Marçal; Gilles Guillemin; Fanny Rossi; Mirielle Chinian; Dominique Laurent; Charles Teo; Brett A Neilan
Journal:  Neurotox Res       Date:  2016-10-29       Impact factor: 3.911

4.  Delivery of chemotropic proteins and improvement of dopaminergic neuron outgrowth through a thixotropic hybrid nano-gel.

Authors:  Elisa Tamariz; Andrew C A Wan; Y Shona Pek; Magda Giordano; Genoveva Hernández-Padrón; Alfredo Varela-Echavarría; Iván Velasco; Víctor M Castaño
Journal:  J Mater Sci Mater Med       Date:  2011-07-09       Impact factor: 3.896

5.  Axonal Growth of Midbrain Dopamine Neurons is Modulated by the Cell Adhesion Molecule ALCAM Through Trans-Heterophilic Interactions with L1cam, Chl1, and Semaphorins.

Authors:  Christopher R Bye; Valeria Rytova; Walaa F Alsanie; Clare L Parish; Lachlan H Thompson
Journal:  J Neurosci       Date:  2019-07-12       Impact factor: 6.167

6.  Recovery from experimental parkinsonism by semaphorin-guided axonal growth of grafted dopamine neurons.

Authors:  N Emmanuel Díaz-Martínez; Elisa Tamariz; N Fabián Díaz; Claudia M García-Peña; Alfredo Varela-Echavarría; Iván Velasco
Journal:  Mol Ther       Date:  2013-06-04       Impact factor: 11.454

7.  A network view on Parkinson's disease.

Authors:  Sreedevi Chandrasekaran; Danail Bonchev
Journal:  Comput Struct Biotechnol J       Date:  2013-07-14       Impact factor: 7.271

8.  Ascending midbrain dopaminergic axons require descending GAD65 axon fascicles for normal pathfinding.

Authors:  Claudia M García-Peña; Minkyung Kim; Daniela Frade-Pérez; Daniela Avila-González; Elisa Téllez; Grant S Mastick; Elisa Tamariz; Alfredo Varela-Echavarría
Journal:  Front Neuroanat       Date:  2014-06-05       Impact factor: 3.856

Review 9.  Hydrogels as scaffolds and delivery systems to enhance axonal regeneration after injuries.

Authors:  Oscar A Carballo-Molina; Iván Velasco
Journal:  Front Cell Neurosci       Date:  2015-02-17       Impact factor: 5.505

10.  Dopaminergic axon guidance: which makes what?

Authors:  Laetitia Prestoz; Mohamed Jaber; Afsaneh Gaillard
Journal:  Front Cell Neurosci       Date:  2012-07-31       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.